Menu
Innovators in the industry, Calroy Health Sciences translates breakthrough research into transformative products for foundational health needs.
Their mission is to advance science and enhance health for the benefit of healthcare practitioners and their patients. Their model combines rigorous research and development with an exacting approach to sourcing, manufacturing, and transparency.
This groundbreaking work has led to the award of two patents, with more pending. Their flagship product Arterosil HP® contains an extract of rhamnan sulfate (RS) from Monostroma nitidum, a rare green seaweed harvested in the Pacific Ocean. Over the past three decades, significant scientific research has been conducted, primarily focused on how this extract can deliver key benefits to the human vascular system.
Discover the vital role of the glycocalyx in supporting the health of your arteries and heart. This video from Dr Derrick DeSilva explains how the glycocalyx functions as a protective barrier, allowing the blood to flow without impacting the inner wall of the blood vessels. Learn how special nutrients can help support and maintain a healthy glycocalyx, promoting overall cardiovascular well-being.
Their mission is to advance science and enhance health.
A wide range of research and papers of interest focused on nitric oxide and the vascular system.
Comprehensive research and papers of interest focused on the endothelial glycocalyx, the fragile inner lining of the entire vascular system.
Comprehensive research and papers of interest focused on rhamnan sulfate from the rare green seaweed Monostroma nitidum
Mon – Fri 8am to 5.00pm NZT
orders@fxmed.co.nz
support@fxmed.co.nz
NZ customers
Free Phone: 0800 439 633
Free Fax: 0800 439 630
Australian customers
Free Phone: 1800 770 904
Free Fax: 1800 665 070
Please note that all products and services found on this website are available to patients through their health practitioner only.
New to FxMed? Set up your account and access leading brands trusted by practitioners in Australia and New Zealand.